Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa SaigohTakao TakeshimaMasami NakaiYoshiyuki ShibasakiMiki IshidaXiaoping NingSteve BarashYuki IsogaiNobuyuki Koga

Published in: Journal of pain research (2023)

Despite the limitations of subgroup analyses, these consistent results confirm the efficacy and tolerability of fremanezumab in Japanese patients with CM.

Keyphrases

open label
phase iii
randomized controlled trial